SCHEMBL30285506

SCHEMBL30285506

CS(=O)(=O)c1c(Oc2cccc(-c3ncc(C(N)c4ccccc4)[nH]3)c2)c(F)cc2[nH]ccc12

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ BACE1 P56817 3/20 0.36
▸ BACE2 Q9Y5Z0 3/20 0.36
▸ NR1H2 P55055 2/20 0.33
▸ NR1H3 Q13133 1/20 0.33
▸ GRIN2D O15399 1/20 0.32
▸ GRIN3B O60391 1/20 0.32
▸ GRIN1 Q05586 1/20 0.32
▸ GRIN2A Q12879 1/20 0.32
▸ GRIN2B Q13224 1/20 0.32
▸ GRIN2C Q14957 1/20 0.32
▸ GRIN3A Q8TCU5 1/20 0.32
▸ SDHB P21912 1/20 0.32
▸ BRD4 O60885 1/20 0.32
▸ DHODH Q02127 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.30
▸ LMNA P02545 1/20 0.30
▸ MAPT P10636 1/20 0.30
▸ NPSR1 Q6W5P4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29336584 1.00 BACE1 (0.36) BACE1BACE2NR1H2NR1H3GRIN2D
SCHEMBL30285449 0.90 BACE1 (0.37) BACE1BACE2NR1H2NR1H3GRIN2D
SCHEMBL29336583 0.90 BACE1 (0.37) BACE1BACE2NR1H2NR1H3GRIN2D
SCHEMBL30285518 0.81 PIN1 (0.36) BACE1BACE2NR1H2NR1H3GRIN2D
SCHEMBL29336772 0.81 PIN1 (0.36) BACE1BACE2NR1H2NR1H3GRIN2D
SCHEMBL29336940 0.81 BRD4 (0.32) BRD4
SCHEMBL30285454 0.81 BRD4 (0.32) BRD4
SCHEMBL29336566 0.80 KDM4E (0.35) BACE1BACE2NR1H2NR1H3GRIN2D
SCHEMBL30285379 0.80 KDM4E (0.35) BACE1BACE2NR1H2NR1H3GRIN2D
SCHEMBL29336768 0.77 GRIN2D (0.33) BACE1BACE2GRIN2DGRIN3BGRIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4396176-A1 INDOLE COMPOUNDS AND USES THEREOF IN THE TREATEMENT OF CYSTIC FIBROSIS GENZYME CORPORATION (US) 2024-07-10 — — EP disclosed
WO-2023034946-A1 INDOLE COMPOUNDS AND USES THEREOF IN THE TREATEMENT OF CYSTIC FIBROSIS GENZYME CORPORATION (US) 2023-03-09 — — WO disclosed
Send feedback